ABIOMED Inc. (NASDAQ: ABMD) was raised to Overweight from Neutral at Piper Jaffray.
Cardinal Health Inc. (NYSE: CAH) was raised to Outperform at Evercore ISI Group.
Cedar Fair L.P. (NYSE: FUN) was started as Buy and assigned an $81 price target (versus a $68.04 close) at Goldman Sachs.
DXC Technology Co. (NYSE: DXC) was raised to Overweight from Equal Weight with an $85 price target (versus a $71.79 close) at Morgan Stanley.
InnerWorkings Inc. (NASDAQ: INWK) was started as Buy and assigned a $12 price target (versus a $9.70 close) at Wunderlich.
Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) found itself in an analyst horse race on Thursday, but shares were indicated up 6% at $149.45. It was downgraded to Neutral from Buy and the price target was cut to $150 from $162 at Mizuho. Jazz was raised to Buy with a $175 fair value estimate at Janney.
Retrophin Inc. (NASDAQ: RTRX) was started with an Outperform rating at William Blair.
Rexahn Pharmaceuticals Inc. (NYSEMKT: RNN) was started as Buy and assigned a $2 price target (versus a $0.62 close) at Rodman & Renshaw.
Six Flags Entertainment Corp. (NYSE: SIX) was started as Neutral and assigned a $65 price target (versus a $57.59 close) at Goldman Sachs.
Superconductor Technologies Inc. (NASDAQ: SCON) was raised to Buy with a $3 price target (versus a $1.46 close) at Rodman & Renshaw.
Teladoc Inc. (NYSE: TDOC) was downgraded to Neutral from Buy at Cantor Fitzgerald.
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was assumed with a Hold rating but the price target was slashed to $66 from $109 (versus a $61.71 close) at Jefferies.
In the oil and energy sector, Jefferies reiterated its Buy ratings on Chevron, Royal Dutch Shell and Marathon Oil, but the firm kept its Hold ratings on Exxon Mobil, ConocoPhillips, Occidental and Total.
Deutsche Bank still sees big upside for financials.
A 25% corporate tax rate could boost 5 great companies.
Wednesday’s top analyst calls were in shares of AstraZeneca, Hasbro, Roche, Peabody Energy, Suncor, Wynn Resorts and many more.